52 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
PACB Pacific Biosciences of California, Inc. $5.14 $678.18M N/A
Article Searches
Better Buy: Illumina, Inc. vs. Pacific Biosciences https://www.fool.com/investing/2017/12/11/better-buy-illumina-inc-vs-pacific-biosciences.aspx?source=iedfolrf0000001 Dec 11, 2017 - One of these vendors of gene sequencing instruments is flexing its muscles and the other is struggling.
Why Illumina Rose 18.7% in August https://www.fool.com/investing/2017/09/07/why-illumina-rose-187-in-august.aspx?source=iedfolrf0000001 Sep 07, 2017 - The market cheered blowout quarterly results.
Pacific Biosciences of California (PACB) Presents At Photonics Summit and Workshop - Slideshow https://seekingalpha.com/article/4104472-pacific-biosciences-california-pacb-presents-photonics-summit-workshop-slideshow?source=feed_all_articles Sep 06, 2017 - The following slide deck was published by Pacific Biosciences of California in conjunction with this event.
What's Behind Pacific Biosciences of California's Stock Rally Today? https://www.fool.com/investing/2017/08/07/whats-behind-pacific-biosciences-of-californias-st.aspx?source=iedfolrf0000001 Aug 07, 2017 - Shares of the high-accuracy genomic sequencing company continue to rise despite a lack of significant news.
Here's Why Pacific Biosciences of California Is Surging Today https://www.fool.com/investing/2017/08/03/heres-why-pacific-biosciences-of-california-is-sur.aspx?source=iedfolrf0000001 Aug 03, 2017 - The sequencing company topped off a solid second-quarter earnings report with news of a big order from its best customer.
Pacific Biosciences of California Struggles in the Second Quarter With Lower Sales https://www.fool.com/investing/2017/08/03/pacific-biosciences-of-california-struggles-in-sec.aspx?source=iedfolrf0000001 Aug 03, 2017 - The genetic-sequencing company's lone bright spot was higher product sales, but it wasn't enough to offset the loss of contract revenue.
Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q2 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4094051-pacific-biosciences-californias-pacb-ceo-mike-hunkapiller-q2-2017-results-earnings-call?source=feed_sector_healthcare Aug 03, 2017 - Pacific Biosciences of California (NASDAQ:PACB) Q2 2017 Earnings Conference Call August 2, 2017 04:30 PM ET Executives Trevin Rard - IR Mike Hunkapiller - CEO Susan Barnes - CFO Ben Gong - VP of Finan
Pacific Biosciences (PACB) Prices Offering of Common Stock http://www.zacks.com/stock/news/264515/pacific-biosciences-pacb-prices-offering-of-common-stock?cid=CS-ZC-FT-264515 Jun 16, 2017 - Pacific Biosciences of California, Inc. (PACB) recently announced that it has priced its underwritten public offering of 15.4 million shares of its common stock.
The Two Reasons Why Illumina Rose 8.3% In April https://www.fool.com/investing/2017/05/10/why-illumina-rose-83-in-april.aspx?source=iedfolrf0000001 May 10, 2017 - A new product launch and upbeat first-quarter results caused Illumina's stock to rally.
This Is the Big Reason Behind Pacific Biosciences of California, Inc.'s 24% Tumble in April https://www.fool.com/investing/2017/05/03/this-is-the-big-reason-behind-pacific-biosciences.aspx?source=iedfolrf0000001 May 03, 2017 - Despite topping Q1 revenue estimates, another figure in Pacific Biosciences quarterly report doomed its stock.

Pages: 123456

<<<Page 4>